Inducible pluripotent stem cells: not quite ready for prime time?
- 1 February 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 15 (1) , 61-67
Abstract
Inducible pluripotent stem (iPS) cells derived from somatic cells represent a novel renewable source of tissue precursors. The potential of iPS cells is considered to be at least equivalent to that of human embryonic stem cells, facilitating the treatment or cure of diseases such as diabetes mellitus, spinal cord injuries, cardiovascular disease, and neurodegenerative diseases, but with the potential added benefit of evading the adaptive immune response that otherwise limits allogeneic cell-based therapies. This review discusses recent advances in pluripotency induction and the use of iPS cells to produce differentiated cells, while highlighting roadblocks to the widespread use of this technology in the clinical arena. Whereas ethical and safety issues surrounding the use of human embryonic stem cells for the treatment of disease continue to be debated, use of iPS cells may be viewed as a more widely acceptable compromise. Since the first descriptions of inducible pluripotency from somatic cells, multiple laboratories have collectively made tremendous strides both in developing alternative, more clinically acceptable, induction strategies and in demonstrating the proof-of-principle that iPS cells can be differentiated into a variety of cell types to reverse mouse models of human disease. Although the prospect of using patient-specific iPS cells has much appeal from an ethical and immunologic perspective, the limitations of the technology from the standpoint of reprogramming efficiency and therapeutic safety necessitate much more in-depth research before the initiation of human clinical trials.Keywords
This publication has 73 references indexed in Scilit:
- Transplantation of mouse induced pluripotent stem cells into the cochleaNeuroReport, 2009
- In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytesBiochemical and Biophysical Research Communications, 2009
- Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells—Brief ReportArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Generation of retinal cells from mouse and human induced pluripotent stem cellsNeuroscience Letters, 2009
- Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature PigJournal of Biological Chemistry, 2009
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- Generation of induced pluripotent stem cells from human bloodBlood, 2009
- Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem CellsStem Cells, 2009
- A Comparison of Murine Smooth Muscle Cells Generated from Embryonic versus Induced Pluripotent Stem CellsStem Cells and Development, 2008